Dna X (SONM) Change in Receivables (2018 - 2025)
Dna X filings provide 8 years of Change in Receivables readings, the most recent being $1.3 million for Q4 2025.
- On a quarterly basis, Change in Receivables rose 6.16% to $1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.1 million, a 115.09% increase, with the full-year FY2025 number at $1.1 million, up 115.09% from a year prior.
- Change in Receivables hit $1.3 million in Q4 2025 for Dna X, up from $1.1 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $11.0 million in Q3 2022 to a low of -$6.5 million in Q1 2024.
- Median Change in Receivables over the past 5 years was $1.0 million (2021), compared with a mean of $796600.0.
- The widest YoY moves for Change in Receivables: up 902.65% in 2021, down 829.66% in 2021.
- Dna X's Change in Receivables stood at $8.2 million in 2021, then fell by 24.88% to $6.1 million in 2022, then plummeted by 179.43% to -$4.9 million in 2023, then surged by 124.91% to $1.2 million in 2024, then grew by 6.16% to $1.3 million in 2025.
- The last three reported values for Change in Receivables were $1.3 million (Q4 2025), $1.1 million (Q3 2025), and -$2.0 million (Q2 2025) per Business Quant data.